The MYC-YBX1 Circuit in Maintaining Stem-like Vincristine-Resistant Cells in Rhabdomyosarcoma

SIMPLE SUMMARY: Rhabdomyosarcoma (RMS) is a devastating pediatric sarcoma. In particular, patients with relapsed disease have very poor survival outcomes. However, there has not been any significant change in therapy options for the last three or four decades, and the mechanisms underlying treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Fritzke, Madeline, Chen, Kenian, Tang, Weiliang, Stinson, Spencer, Pham, Thao, Wang, Yadong, Xu, Lin, Chen, Eleanor Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216535/
https://www.ncbi.nlm.nih.gov/pubmed/37345125
http://dx.doi.org/10.3390/cancers15102788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216535/
https://www.ncbi.nlm.nih.gov/pubmed/37345125
http://dx.doi.org/10.3390/cancers15102788

Ejemplares similares